» Authors » Dacita Suen

Dacita Suen

Explore the profile of Dacita Suen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 288
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ng D, So S, Fielding R, Mehnert-Theuerkauf A, Kwong A, Suen D, et al.
Front Public Health . 2024 Mar; 12:1340920. PMID: 38463159
Introduction: Existing evidence of returning-to-work (RTW) after cancer comes predominately from Western settings, with none prospectively examined since the initial diagnostic phase. This study prospectively documents RTW-rate, time-to-RTW, work productivity...
2.
3.
Man V, Suen D, Kwong A
Ann Surg Oncol . 2023 Feb; 30(6):3237-3244. PMID: 36849573
Background: The objective of this study is to compare the efficacy of the superparamagnetic iron oxide (SPIO)-guided and standard techniques for sentinel lymph node (SLN) detection in early breast cancer....
4.
Ng D, Fielding R, Tsang C, Ng C, Chan J, Or A, et al.
BMJ Open . 2023 Jan; 13(1):e065075. PMID: 36669845
Introduction: Fear of cancer recurrence (FCR) is a prevalent and frequently debilitating response to a cancer diagnosis, affecting a substantial proportion of cancer survivors. Approximately 30% of local Hong Kong...
5.
Co M, Lam L, Suen D, Kwong A
Clin Breast Cancer . 2022 Nov; 23(1):e14-e19. PMID: 36384818
Background: This is a systematic review of randomized controlled trials (RCT) comparing the use of axillary reverse mapping (ARM) with conventional technique for axillary dissection (AD) in breast cancer surgery....
6.
Li B, Yau T, Leung R, Kwok G, Tsang J, Cheung P, et al.
Adv Ther . 2021 Oct; 38(12):5752-5762. PMID: 34699004
Introduction: Concurrent anthracycline and taxane is an effective and efficient way to deliver neoadjuvant chemotherapy for HER2-negative breast cancers. Data on efficacy and tolerance to 6 cycles of concurrent docetaxel,...
7.
Ng D, Foo C, Ng S, Kwong A, Suen D, Chan M, et al.
Psychooncology . 2019 Oct; 29(2):271-279. PMID: 31663187
Objective: This longitudinal study mapped distinct trajectories of fear of cancer recurrence (FCR) over 12 months among patients with breast (BC) or colorectal (CRC) cancer, and examined if metacognition, indirectly...
8.
Chiu J, Leung R, Tang V, Cheuk W, Lo J, Kwok G, et al.
Postgrad Med J . 2019 Apr; 95(1121):155-161. PMID: 31004045
Background: Over the last 10 years, there has been a major treatment revolution for early human epidermal growth factor receptor 2 (HER2)-positive breast cancer. We aimed to explore the outcome...
9.
Ng D, Kwong A, Suen D, Chan M, Or A, Ng S, et al.
Psychooncology . 2019 Apr; 28(6):1243-1251. PMID: 30932279
Objective: Fear of cancer recurrence (FCR) represents a chronic burden for many cancer survivors. We determined FCR prevalence and potential correlates, specifically metacognitive styles and neuroticism among Chinese cancer survivors...
10.
Man V, Wong T, Co M, Suen D, Kwong A
World J Surg . 2019 Mar; 43(8):1991-1996. PMID: 30888473
Background: The combined use of radioisotope and blue dye is the gold standard in sentinel lymph node (SLN) localization in early breast cancer. Superparamagnetic iron oxide (SPIO) has recently emerged...